We are independent & ad-supported. We may earn a commission for purchases made through our links.

Advertiser Disclosure

Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.

How We Make Money

We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently from our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.

What is Pituitary Dwarfism?

By J.M. Willhite
Updated Mar 03, 2024
Our promise to you
The Health Board is dedicated to creating trustworthy, high-quality content that always prioritizes transparency, integrity, and inclusivity above all else. Our ensure that our content creation and review process includes rigorous fact-checking, evidence-based, and continual updates to ensure accuracy and reliability.

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

Editorial Standards

At The Health Board, we are committed to creating content that you can trust. Our editorial process is designed to ensure that every piece of content we publish is accurate, reliable, and informative.

Our team of experienced writers and editors follows a strict set of guidelines to ensure the highest quality content. We conduct thorough research, fact-check all information, and rely on credible sources to back up our claims. Our content is reviewed by subject matter experts to ensure accuracy and clarity.

We believe in transparency and maintain editorial independence from our advertisers. Our team does not receive direct compensation from advertisers, allowing us to create unbiased content that prioritizes your interests.

Individuals of unusually short stature who possess a growth hormone deficiency resulting from impaired pituitary gland function are diagnosed with pituitary dwarfism. Commonly referred to simply as growth hormone deficiency, this condition possesses a good prognosis with early detection and prompt treatment. Those who are diagnosed with this form of dwarfism generally undergo treatment that involves the regular administration of hormone replacement therapy.

The pituitary gland is generally considered a central hub for hormone production, distribution, and regulation. In the presence of this form of dwarfism, the pituitary gland's function is significantly impaired, producing insufficient growth hormone. The disorder most commonly presents as a congenital condition, meaning it is present at birth, and its cause is usually idiopathic, meaning there is no discernible reason for the presentation of the condition. If the pituitary gland is injured, a disruption in hormone production may occur leading to symptom onset. In some cases the presence of disease during one's developmental years, such as certain cancers, may also initiate hormone disruption leading to pituitary dwarfism.

The presence of pituitary dwarfism may first manifest during infancy when the child does not reach key developmental milestones. When the disorder presents later in life, adolescents with the condition may not undergo puberty as their peers do. If the condition presents with other chromosomally mosaic conditions, such as Turner syndrome, the individual may not develop sexually due to the inadequacy or absence of additional key hormones. In some instances, the presence of other chromosomal mosaicisms may induce thyroid and adrenal dysfunction that may also manifest in the presence of pituitary dysfunction. Rarely, pituitary dwarfism may present to a degree during adulthood if the individual has sustained a significant head injury or developed hormonal disruption due to the presence of disease that adversely affects or originates in the pituitary gland.

A diagnosis of pituitary dwarfism is generally confirmed with a physical examination of the individual. His or her physical proportions, including stature and weight are evaluated for appropriateness as determined by his or her age. Those who demonstrate diminished or absent growth will generally register far below the expected average for their age group. Apart from a very young appearance, individuals diagnosed with pituitary dwarfism normally do not demonstrate any pronounced physical characteristics or abnormalities other than being below average in height. In addition to a physical examination, a battery of diagnostic tests may be performed to further support a diagnosis of pituitary dwarfism.

Imaging tests, including X-ray and magnetic resonance imaging (MRI), may be performed to evaluate the age and condition of the individual’s bones and assess whether he or she is demonstrating normal, patterned bone development. Extensive tests may also be performed to evaluate the condition and functionality of his or her hypothalamus and pituitary gland. Additionally, blood tests may be administered to assess hormone levels and check for any deficiencies or markers indicative of disease.

An early diagnosis and the administration of appropriate treatment are key to a successful prognosis in the presence of pituitary dwarfism. Those who respond positively to the administration of growth hormone therapy during the early stages of their development may demonstrate an ability to meet established developmental milestones with regard to height and skeletal maturation before his or her growth plateaus. Complications associated with the regular administration of growth hormone may include widespread joint discomfort and a tendency to retain water and fluids which can lead to weight issues necessitating use of a diuretic to alleviate chronic distention.

The Health Board is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.

Discussion Comments

The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.

The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.